Want to track DGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 54 days
Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now?
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose concerns.
Zacks | 1 year ago
Quest Diagnostics (DGX) Gains From New M&As Amid Competition
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share gains driven by the competitive strength of its scale and innovative offerings.
Zacks | 1 year ago
Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis
Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer diagnosis.
Zacks | 1 year ago
Why Is Quest Diagnostics (DGX) Up 3.1% Since Last Earnings Report?
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Zacks | 1 year ago
2025 © Marketlog. All Rights Reserved.
